Data and disruption: the state of artificial intelligence in life sciences
AI is rapidly transforming the life sciences industry. The quantum leap to advances in drug development, medical data, precision medicine, and clinical trials is intriguing, but what are the practical use cases to get started today? These innovations bring new legal challenges related to intellectual property, data protection, regulatory compliance, and ethical considerations that must be addressed as you venture on your AI journey.
Implementing AI systems requires investments in technology, training, and data infrastructure. Additionally, ensuring AI’s ethical and responsible use in compliance is essential, as regulatory agencies closely monitor these developments. Companies that embrace AI in their compliance strategies will be better positioned to navigate the evolving regulatory landscape and bring innovative, life-saving products to market faster and with greater confidence.
Hosted by USDM Life Sciences, this on-demand event will help you understand AI for regulated GxP use cases, establish a governance model, and identify practical use cases to get you started on your AI journey.
What you’ll learn
- The current state of AI regulations in the GxP compliance landscape and predictions for how they will develop.
- Practical AI use cases in life sciences, including generative AI for regulated and non-regulated data.
- How large language models can be applied to advance life sciences innovations.
- USDM’s AI governance framework and its phases of maturity — learn, control, expand.
- How to get started on a compliant AI journey, from citizen development to reusable, validated applications.
Session 1: Regulatory and Business Impacts of AI
Explore the current state of AI regulations and hear predictions for how they will develop.
- Regulatory GxP compliance landscape
- Update on global regulations and industry's response to AI
- Guidance for the future of AI regulations
Panelists:
- Roger Davy, VP of Consulting, USDM
- John Petrakis, VP of Cloud Assurance, USDM
- Martin Van Trieste, Author and President Emeritus, Civica Rx
- Moderator: Lisa Om, VP of Marketing, USDM
Session 2: AI Fueled Use Cases for Workflow Automation
Join industry experts as they discuss AI use cases and technology advancements in life sciences.
- Practical AI use cases in life sciences
- Operational improvement using generative AI for regulated and non-regulated data
- Large language models to advance innovations
- Live Q&A
Panelists:
- Dr. Andrée Bates, Chairman of the Board/Founder/CEO, Eularis
- Richard Graves, Co-founder & CCO, Sorcero
- Riju Khetarpal, Director, Global Healthcare & Life Sciences ISV Strategy & Ecosystem, Google
- John Petrakis, VP of Cloud Assurance, USDM
- Moderator: Lisa Om, VP of Marketing, USDM
Session 3: AI Governance Framework
Learn how USDM addresses compliance and security to help evolve your company’s AI maturity.
- USDM’s AI governance framework
- Phases of maturity: learn, control, expand
- Citizen development, compliance, and reusable applications
- How to get started
- Live Q&A
Panelists:
- David Blewitt, VP of Cloud Compliance, USDM
- John Petrakis, VP of Cloud Assurance, USDM
- Moderator: Lisa Om, VP of Marketing, USDM
The USDM point of view: AI delivers the most value in life sciences when it is governed from the start, not retrofitted for compliance later. Regulators are watching how these systems are built and used, so the organizations that pair practical AI use cases with a clear governance model — covering data integrity, validation, and security — will be the ones that scale AI safely and bring innovative products to market with confidence.
Who Should Attend:
Industry / Company Type
- Pharma
- BioPharma
- Biotechnology
- Medical Device
- CRO / CMO
- Any regulated life sciences organization
Relevant Roles / Job Titles
Relevant IT Titles
- Chief Information Officer (CIO) / Chief Technology Officer (CTO) / Chief Systems Office (CSO)
- Head of Cloud Infrastructure & Cybersecurity Security
- VP of IT / Director of IT / Associate Director of IT / Manager of IT
- VP/Director of IT Infrastructure
- Director/Manager of GxP Applications
- Director/Manager of R&D Applications
- Cloud Architect/Cloud Developers
- Cloud Engineer / Computer Systems Validation Engineer / Validation Engineer
Relevant Quality Titles
- Chief Compliance Officer (Healthcare)
- Head of Quality Assurance
- VP/Director/Manager of Quality Assurance (QA)
- Systems Compliance, QA Regulatory Affairs
- VP/Director of Quality Engineering
- VP/Director of Document Control
Relevant Regulatory Titles
- Head/VP/Director/Manager of Regulatory Affairs
- Head/VP/Director/Manager Regulatory Operations
- Head/VP/Director/Manager of Compliance
Other Relevant Titles
- VP/Director/Manager of Clinical Operations
- VP/Director/Manager of Translational Research
- VP/Director/Manager R&D
- VP/Director/Manager of Research Operations
- VP/Director/Manager Labs
FAQ: USDM Life Sciences Summit 2024
What does the USDM Life Sciences Summit 2024 cover?
The on-demand event covers the state of artificial intelligence in life sciences across three sessions: the regulatory and business impacts of AI, AI-fueled use cases for workflow automation, and an AI governance framework for compliant adoption.
Who should watch this on-demand event?
It is designed for regulated life sciences organizations — pharma, biopharma, biotechnology, medical device, and CRO/CMO companies — and for IT, quality, regulatory, clinical, and R&D leaders responsible for adopting AI in GxP environments.
How does USDM approach AI governance?
USDM presents an AI governance framework built around phases of maturity — learn, control, and expand — that addresses compliance and security while enabling citizen development and reusable, validated applications.
How do AI initiatives stay compliant in regulated GxP environments?
Compliant AI starts with the same disciplines that govern any validated system — sound cloud assurance, data integrity, and security — applied to how AI systems are built, validated, and monitored. The summit explores how to align AI adoption with the evolving GxP regulatory landscape.
How can I get started with AI in my organization?
The event outlines practical, low-risk use cases to begin with and how to establish a governance model before scaling. To discuss your AI journey with USDM, contact our team.
Watch on demand. The full USDM Life Sciences Summit 2024 — all three sessions and live Q&A — is available to stream on demand. Watch the on-demand event, or contact USDM to talk through a compliant AI strategy for your organization.